Trials / Enrolling By Invitation
Enrolling By InvitationNCT07180797
Proficiency-Based Progression on Hugo Ras Robot for Learning Nerve-Sparing RARP: Feasibility Study
- Status
- Enrolling By Invitation
- Phase
- —
- Study type
- Observational
- Enrollment
- 12 (estimated)
- Sponsor
- Orsi Academy · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Feasibility study 1. To evaluate the feasibility of PBP training for nerve-sparing RARP on the Hugo Ras system 2. To assess time to proficiency for participants with varying experience 3. To identify challenges in PBP RARP training through observed errors and feedback
Detailed description
As robotic surgery advances, the emergence of new platforms such as the Hugo™ Robotic-Assisted Surgery System calls for robust training frameworks. Proficiency-Based Progression (PBP) provides a structured method to ensure skill acquisition through clearly defined, measurable benchmarks. This study evaluates the feasibility of implementing a PBP curriculum to train urologists in nerve-sparing robot-assisted radical prostatectomy (RARP) using the Hugo™ system. Twelve urologists and urology residents will participate, divided into three groups based on experience: Robotic-naïve Intermediate (Da Vinci experience only) Expert RARP surgeons (Da Vinci experience without prior Hugo exposure) The PBP training pathway comprises: Cognitive modules (e-learning with MCQ validation) Psychomotor skills training (device familiarization and basic surgical skills) Procedural training (nerve-sparing RARP on porcine models) Performance will be evaluated both in real time and via blinded video review. Primary endpoints include the time to reach proficiency in basic skills and procedural steps, analyzed by prior experience. Secondary endpoints encompass error profiles, participant and instructor feedback, and the feasibility of standardizing proficiency metrics.
Conditions
Timeline
- Start date
- 2025-09-12
- Primary completion
- 2026-02-01
- Completion
- 2026-03-01
- First posted
- 2025-09-18
- Last updated
- 2025-09-18
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT07180797. Inclusion in this directory is not an endorsement.